Most people who get told they have insulin resistance hear it in one of two contexts. Either it comes attached to a PCOS diagnosis, or it comes up during a general health check with a comment about blood sugar levels trending in the wrong direction. What rarely happens is someone explaining clearly what insulin resistance is actually doing to the reproductive system, and why it matters for fertility even in women who don’t have PCOS at all.
That gap in the conversation is worth addressing. Because insulin resistance is more common than most people realise, it’s detectable with fairly standard tests, and its effects on fertility are real and in many cases addressable.
What is insulin resistance , without the jargon?
The basic mechanism
When you eat carbohydrates, blood glucose rises. The pancreas respond by releasing insulin, which signals cells throughout the body to take up and use that glucose. Insulin resistance means those cells have become less responsive to that signal. The glucose doesn’t get cleared as efficiently, so the pancreas produces more insulin to compensate.
Why normal blood sugar doesn’t mean there is no problem?
For a while, blood sugar stays in a normal range because the pancreas is working harder. What shows up instead is elevated fasting insulin, a high HOMA-IR score (a calculated ratio of fasting glucose and insulin that reflects insulin sensitivity), and eventually, if the compensatory mechanism fails, elevated blood glucose.
The fertility-relevant part isn’t just about blood sugar. Insulin is a metabolic signalling molecule with effects that extend into the hormonal systems governing reproduction.
The PCOS connection, and why it’s not the whole story
How insulin drives androgen excess in PCOS
Insulin resistance and PCOS are so frequently discussed together that they’ve become almost synonymous in patient-facing fertility content. The connection is real: a significant proportion of women with PCOS have insulin resistance, and hyperinsulinaemia, elevated circulating insulin, is one of the mechanisms driving the androgen excess that characterises many PCOS presentations. Insulin stimulates the ovarian theca cells to produce more androgens, including testosterone. Elevated androgens disrupt follicle development and ovulation.
The women who get missed
But insulin resistance exists independently of PCOS. Women without PCOS can have significant insulin resistance. Women with a normal BMI can have significant insulin resistance. And in those women, the fertility effects can be present and unrecognised for a long time, particularly if no one thinks to look because PCOS has been excluded.
The association between insulin resistance and fertility problems outside PCOS is less prominently discussed in clinical settings than it deserves to be. Irregular ovulation, implantation difficulties, higher early pregnancy loss rates, and poorer IVF outcomes have all been studied in relation to insulin resistance. The evidence isn’t uniformly strong across all of these, and causal claims need to be made carefully, but there’s enough of a signal to make testing for insulin resistance a reasonable part of the workup in women with unexplained fertility difficulties.
How insulin resistance interferes with reproduction
The effect on sex hormone balance
Elevated insulin suppresses sex hormone-binding globulin (SHBG), a protein that binds testosterone and limits its biological activity. Lower SHBG means more free testosterone circulating, with downstream effects on ovulation and follicle development.
The ovulation disruption
Hyperinsulinaemia interacts with the hypothalamic-pituitary axis in ways that affect LH pulse patterns, which in turn affect the hormonal cascade needed for reliable ovulation. This can produce the kind of irregular cycles that get labelled as unexplained without anyone investigating the metabolic root.
The implantation question
There’s also an emerging picture around endometrial receptivity. Some research suggests that insulin resistance may affect the endometrial environment in ways that impair implantation, through inflammatory pathways and changes in endometrial gene expression. The evidence here is less settled than for ovulatory effects, but it’s an active area of research.
IVF specifically
In the context of IVF, insulin resistance has been associated in some studies with poorer ovarian response to stimulation, higher rates of cycle cancellation, and lower clinical pregnancy rates. The relationship is complex and not universally replicated across all studies, but it’s present enough that assessing and addressing insulin sensitivity before an IVF cycle is a reasonable clinical consideration.
Who might have this without knowing it
Why it stays hidden
One of the more frustrating aspects of insulin resistance from a fertility perspective is how long it can go undetected. Standard health checks often don’t include fasting insulin. Blood glucose might be completely normal while fasting insulin is significantly elevated. Someone can have meaningful insulin resistance on HOMA-IR calculation while their glucose looks fine on a basic panel.
Signs that are easy to overlook
The clinical features that sometimes accompany insulin resistance include irregular periods, difficulty losing weight despite reasonable effort, fatigue after carbohydrate-heavy meals, skin changes like acanthosis nigricans (darkening of skin in the neck, armpits, or groin folds), and a waist-to-hip ratio that reflects central adiposity. Not all of these will be present, and some women with significant insulin resistance have none of them.
A note on Indian patients specifically
A family history of type 2 diabetes or gestational diabetes is relevant. South Asian populations, including Indian women specifically, have higher rates of insulin resistance at lower BMI thresholds than Western reference populations, which is clinically significant when interpreting results.
Testing: what to ask for
The right tests
If insulin resistance hasn’t been assessed and any of the above resonates, the relevant tests are fasting glucose, fasting insulin, and a HOMA-IR calculation from those two values. An HbA1c gives a picture of longer-term glucose regulation. A full lipid panel often accompanies this because insulin resistance and dyslipidaemia tend to co-occur.
Interpreting results in an Indian context
The standard cut-offs used in Western populations for what constitutes normal insulin sensitivity may need to be interpreted with caution in Indian patients, given ethnic differences in insulin sensitivity. This is worth discussing with whoever is reviewing the results.
What can actually be done about it
Diet and lifestyle: the foundation
Dietary and lifestyle modification is the first-line approach to improving insulin sensitivity, and the evidence that it works is reasonably strong. Reducing refined carbohydrate intake, increasing fibre, prioritising lower glycaemic index foods, and regular moderate exercise, particularly resistance training and aerobic exercise in combination, all improve insulin sensitivity over time. These aren’t minor adjustments, and the degree of benefit depends on how consistently they’re applied.
Timing the intervention around fertility treatment
For women trying to conceive, the timeline matters. Improving insulin sensitivity takes months, and waiting for idealised metabolic improvement before starting fertility treatment isn’t always the right call. The decision about when to act on the fertility side versus when to invest more time in metabolic optimisation depends on age, the degree of insulin resistance, and what’s driving the fertility difficulty.
Metformin: what it does and who it’s for
Metformin is the most commonly used pharmacological agent for insulin resistance in the fertility context. It works primarily by reducing hepatic glucose production and improving peripheral insulin sensitivity. In women with PCOS and insulin resistance, metformin has evidence supporting improvement in ovulation rates and, in some studies, reduced miscarriage rates and improved IVF outcomes. The evidence for metformin fertility benefit in women without PCOS but with insulin resistance is less robust, though it’s used in this group at some centres.
Tolerability and side effects
Metformin’s most common side effects are gastrointestinal: nausea, diarrhoea, and abdominal discomfort, particularly when starting the medication or at higher doses. Extended-release formulations are generally better tolerated. It’s typically continued through the first trimester in pregnancy in women with PCOS, though the decision to continue is made on a case-by-case basis.
Inositol: the gentler alternative
Inositol supplementation, particularly myo-inositol and D-chiro-inositol, has attracted attention as an option for improving insulin sensitivity with a gentler side effect profile than metformin. The evidence for inositol is most established in PCOS, where several trials have shown improvements in ovulation and hormonal parameters. Whether it confers the same benefits in insulin-resistant women without PCOS is less clear. It’s widely used and generally considered low-risk, but the evidence base outside PCOS is modest.
Two hypothetical profiles that show how this plays out
A 31-year-old with irregular cycles, confirmed ovulation on approximately 60 percent of monitored cycles, and normal findings on standard fertility workup including AMH, antral follicle count, and semen analysis. She’s been told the infertility is unexplained. Her BMI is 26. Nobody has tested her insulin levels. Fasting insulin comes back elevated, with a HOMA-IR above 2.5. She has no PCOS on ultrasound criteria. In a profile like this, insulin resistance is a plausible contributor to the irregular ovulation pattern that hasn’t been identified because it wasn’t looked for. A three-month trial of dietary modification and metformin before any further fertility treatment is a reasonable next step.
A different profile: a 35-year-old with confirmed PCOS and insulin resistance preparing for IVF after two failed ovarian stimulation cycles with poor response. Both cycles were stimulated on standard protocols without metabolic optimisation. In this profile, reviewing and addressing insulin sensitivity before a third cycle makes clinical sense. Some evidence suggests that improving insulin sensitivity before IVF stimulation may improve ovarian response in insulin-resistant PCOS patients. The cycle is delayed by two to three months while metformin is initiated and dietary changes are implemented. Whether this changes the outcome is uncertain, but the intervention is low-risk and potentially relevant.
The reason it gets missed
A gap in the standard fertility workup
Fertility workups are structured around a defined set of investigations: ovarian reserve, tubal patency, uterine structure, semen analysis. Metabolic assessment doesn’t sit neatly in that framework, and unless someone specifically thinks to look, insulin resistance can remain unidentified while everything else is investigated repeatedly.
Who should ask for this test
The women most likely to benefit from this investigation are those with irregular cycles, unexplained infertility, recurrent early pregnancy loss, or poor IVF response where the standard explanations don’t fully account for what’s happening. South Asian women specifically are worth screening even in the absence of obvious metabolic features, given the population-level differences in insulin sensitivity.
Asking for a fasting insulin level alongside the standard fertility panel is a small addition to an investigation that already involves blood tests. The information it provides may or may not change the clinical plan. But finding out is straightforward.
Book a consultation at 9M Fertility.
→ Also read: Unexplained Infertility: When Tests Are Normal but You Can’t Conceive
→ Also read: Recurrent Miscarriage: Causes, Tests and When to See a Specialist
